LABETALOL (TRANDATE, GLAXO-INC - NORMODYNE, SCHERING-CORP)

被引：9

作者：

CARTER, BL

机构：

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1983年 / 17卷 / 10期

关键词：

D O I：

10.1177/106002808301701001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：704 / 712

页数：9

共 129 条

[1] BIOCHEMICAL EVIDENCE FOR DUAL ACTION OF LABETALOL ON ALPHA-ADRENOCEPTORS AND BETA-ADRENOCEPTORS [J].

AGGERBECK, M ;

GUELLAEN, G ;

HANOUNE, J .

BRITISH JOURNAL OF PHARMACOLOGY, 1978, 62 (04) :543-548

[2]

ANDERSSON O, 1976, BRIT J CLIN PHARMACO, V3, P757

[3]

BAILEY RR, 1977, LANCET, V2, P720

[4] LABETALOL IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND RENAL FUNCTIONAL IMPAIRMENT [J].

BAILEY, RR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 :S135-S140

[5] ENDOCRINE AND METABOLIC EFFECTS OF LABETALOL IN MAN [J].

BARBIERI, C ;

FERRARI, C ;

CALDARA, R ;

CROSSIGNANI, RM ;

BERTAZZONI, A .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (05) :986-991

[6] LABETALOL COMPARED WITH PRINDOLOL PLUS HYDRALLAZINE IN TREATMENT OF HYPERTENSION - DOUBLE-BLIND CROSSOVER STUDY [J].

BARNETT, AJ ;

KALOWSKI, S ;

GUEST, C .

MEDICAL JOURNAL OF AUSTRALIA, 1978, 1 (02) :105-109

[7]

BOAKES AJ, 1973, BRIT J PHARMACOL, V47, pP673

[8]

BOLLI P, 1976, BRIT J CLIN PHARMACO, V3, P765

[9]

BOLLI P, 1977, NEW ZEAL MED J, V86, P557

[10]

BRECKENRIDGE AM, 1977, BRIT J CLINICAL PHAR, V4, pP338

← 1 2 3 4 5 6 7 8 9 10 →